Non-telomeric epigenetic and genetic changes are associated with the inheritance of shorter telomeres in mice

Chromosoma

Volumn 122, Issue 6, 2013, Pages 541-554

  Roberts, Amity R ^a,b   Huang, Edward ^a   Jones, Lincoln ^a,b   Daxinger, Lucia ^a,c   Chong, Suyinn ^a,d   Whitelaw, Emma ^a,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOSOMAL INHERITANCE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; DYSKERATOSIS CONGENITA; EPIGENETICS; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC STABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NULL ALLELE; TELOMERE SHORTENING; TRANSGENE; ZYGOTE;

MUS;

ANIMALS; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; DYSKERATOSIS CONGENITA; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC LOCI; GREEN FLUORESCENT PROTEINS; INBREEDING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; PEDIGREE; RNA; TELOMERASE; TELOMERE; TRANSGENES;

EID: 84889093536     PISSN: 00095915     EISSN: 14320886     Source Type: Journal    
DOI: 10.1007/s00412-013-0427-8     Document Type: Article

References (43)

1. Armanios M (2009) Syndromes of telomere shortening. Annu Rev Genom Hum Genet 10(1):45-61
2. Armanios M, Chen J-L, Chang Y-PC, Brodsky RA, Hawkins A, Griffin CA, Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW (2005) Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. PNAS 102(44):15960-15964
3. Ashe A, Morgan DK, Whitelaw NC, Bruxner TJ, Vickaryous NK, Cox LL, Butterfield NC, Wicking C, Blewitt ME, Wilkins SJ, Anderson GJ, Cox TC, Whitelaw E (2008) A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development. Genome Biol 9(12):R182
4. Blasco MA, Lee H-W, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91(1):25-34
5. Blewitt ME, Gendrel A-V, Pang Z, Sparrow DB, Whitelaw N, Craig JM, Apedaile A, Hilton DJ, Dunwoodie SL, Brockdorff N, Kay GF, Whitelaw E (2008) SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nat Genet 40(5):663-669
6. Blewitt ME, Vickaryous NK, Hemley SJ, Ashe A, Bruxner TJ, Preis JI, Arkell R, Whitelaw E (2005) An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. PNAS 102(21):7629-7634
7. Chin L, Artandi SE, Shen Q, Tam A, Lee S-L, Gottlieb GJ, Greider CW, DePinho RA (1999) p53 eficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97(4):527-538
8. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR (2007) Protein composition of catalytically active human telomerase from immortal cells. Science 315(5820):1850-1853
9. Déjardin J, Kingston RE (2009) Purification of proteins associated with specific genomic loci. Cell 136(1):175-186
10. Dokal I, Vulliamy T (2003) Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev 17(4):217-225
11. Flatscher-Bader T, Foldi CJ, Chong S, Whitelaw E, Moser RJ, Burne THJ, Eyles DW, McGrath JJ (2011) Increased de novo copy number variants in the offspring of older males. Trans Psychiatr 1:e34
12. Gadalla SM, Katki HA, Shebl FM, Giri N, Alter BP, Savage SA (2012) The relationship between DNA methylation and telomere length in dyskeratosis congenita. Aging Cell 11(1):24-28
13. Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 43:405-413, 2, Part 1
14. Hande MP, Samper E, Lansdorp P, Blasco MA (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 144(4):589-601
15. Hao L-Y, Armanios M, Strong MA, Karim B, Feldser DM, Huso D, Greider CW (2005) Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123(6):1121-1131
16. Hao L-Y, Greider CW (2004) Genomic instability in both wild-type and telomerase null MEFs. Chromosoma 113(2):62-68
17. Hartmann N, Boehner M, Groenen F, Kalb R (2010) Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress Anxiety 27(12):1111-1116
18. Hemann MT, Strong MA, Hao L-Y, Greider CW (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107(1):67-77
19. Herbig U, Jobling WA, Chen BPC, Chen DJ, Sedivy JM (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a. Mol Cell 14(4):501-513
20. Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee H-W, Blasco MA (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18(11):2950-2960
21. Kipling D, Cooke H (1990) Hypervariable ultra-long telomeres in mice. Nature 347(6291):400-402
22. Lee H-W, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392(6676):569-574
23. Lindblad K, Schalling M (1999) Expanded repeat sequences and disease. Semin Neurol 19(3):289-299
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25(4):402-408
25. Martínez P, Blasco MA (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11(3):161-176
26. Nakamura AJ, Chiang YJ, Hathcock KS, Horikawa I, Sedelnikova OA, Hodes RJ, Bonner WM (2008) Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin 1:6
27. O'Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J (2010) Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol 17(10):1218-1225
28. Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42(1):301-334
29. Preis JI, Downes M, Oates NA, Rasko JEJ, Whitelaw E (2003) Sensitive flow cytometric analysis reveals a novel type of parent-of-origin effect in the mouse genome. Curr Biol 13(11):955-959
30. Rackley S, Pao M, Seratti GF, Giri N, Rasimas JJ, Alter BP, Savage SA (2012) Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology? Psychosomatics 53(3):230-235
31. Rasko JEJ (2001) Reporters of gene expression: autofluorescent proteins. Wiley, Curr Protoc Cytom
32. Roberts AR, Blewitt ME, Youngson NA, Whitelaw E, Chong S (2011) Reduced dosage of the modifiers of epigenetic reprogramming Dnmt1, Dnmt3L, SmcHD1 and Foxo3a has no detectable effect on mouse telomere length in vivo. Chromosoma 120(4):377-385
33. Savage SA, Alter BP (2009) Dyskeratosis congenita. Hematol Oncol Clin N 23(2):215-231
34. Schoeftner S, Blanco R, de Silanes IL, Muñoz P, Gómez-López G, Flores JM, Blasco MA (2009) Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations. PNAS 106(46):19393-19398
35. She X, Cheng Z, Zollner S, Church DM, Eichler EE (2008) Mouse segmental duplication and copy number variation. Nat Genet 40(7):909-914
36. Simon NM, Smoller JW, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong K-K (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 60(5):432-435
37. Starling JA, Maule J, Hastie ND, Allshire RC (1990) Extensive telomere repeat arrays in mouse are hypervariable. Nucleic Acids Res 18(23):6881-6888
38. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36(5):447-449
39. Walne AJ, Dokal I (2009) Advances in the understanding of dyskeratosis congenita. Br J Haematol 145(2):164-172
40. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A, Kronenberg F, Kiechl S (2010) Telomere length and risk of incident cancer and cancer mortality. JAMA 304(1):69-75
41. Wood JG, Sinclair DA (2002) TPE or not TPE? It's no longer a question. Trends Pharmacol Sci 23(1):1-4
42. Yu W-Y, Chang H-W, Lin C-H, Cho C-L (2008) Short telomeres in patients with chronic schizophrenia who show a poor response to treatment. J Psychiatr Neurosci 33(3):244-247
43. Zglinicki T, Saretzki G, Ladhoff J, d'Adda di Fagagna F, Jackson SP (2005) Human cell senescence as a DNA damage response. Mech Ageing Dev 126(1):111-117